Ortin Global Ltd Stock Price Today (NSE: ORTINGLOBE)
Fundamental Score
Ortin Global Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Ortin Global Ltd share price today is ₹18.06, up +0.00% on NSE/BSE as of 18 February 2026. Ortin Global Ltd (ORTINGLOBE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹10.59 (Cr). The 52-week high for ORTINGLOBE share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of -36.25% and a debt-to-equity ratio of 0.72.
Ortin Global Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Ortin Global Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Ortin Global Share Price: A Financial Analysis & Industry Context
The pharmaceutical industry is currently experiencing a period of intense innovation, demanding companies to be agile and financially sound. This analysis examines the financial health of Ortin Global Ltd, focusing on its current Ortin Global share price and key financial indicators. At a current trading price of ₹12.539999961853027, the stock presents a complex picture due to the absence of a Price-to-Earnings (PE) ratio and a negative Return on Capital Employed (ROCE).
The absence of a PE ratio for Ortin Global suggests that the company is currently not profitable, or its earnings are exceptionally low. This contrasts sharply with established players like
Mankind Pharma Ltd, which boasts a significant market capitalization and generally benefits from investor confidence often reflected in a positive PE ratio. The success of firms like Mankind Pharma can often be attributed to robust management teams and efficient resource allocation. The management quality and the ability to execute business strategies are factors that affect investor confidence which in turn reflect on share prices.A critical area of concern is the -25.11% ROCE. ROCE measures how efficiently a company uses its capital to generate profits. A negative ROCE indicates that Ortin Global is destroying value rather than creating it. This has a direct impact on the company's moat – its competitive advantage. A sustained negative ROCE erodes the company's ability to invest in research and development, marketing, or other initiatives that strengthen its market position, making it vulnerable to competition and impacting investor confidence.
The current financial data suggests that Ortin Global faces considerable challenges. Further in-depth analysis of its debt levels, cash flow, and future growth prospects is warranted. This analysis is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra. This analysis uses publicly available information for observational purposes only and does not constitute financial advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Ortin Global Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ORTINGLOBE across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Strong Cash Generation (₹26.61 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
10 factors identified
Below-Average Return on Equity (-36.25%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-25.11%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-12.65%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Revenue Contraction (-80.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-71.99% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Stagnant Profit Growth (-16.00% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Weak Interest Coverage (-95.00x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Low Promoter Commitment (1.23%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Limited Institutional Interest (FII+DII: 1.68%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Ortin Global Ltd Financial Statements
Comprehensive financial data for Ortin Global Ltd including income statement, balance sheet and cash flow
About ORTINGLOBE (Ortin Global Ltd)
Ortin Global Ltd (ORTINGLOBE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹10.59 (Cr). Ortin Global Ltd has delivered a Return on Equity (ROE) of -36.25% and a ROCE of -25.11%. The debt-to-equity ratio stands at 0.72, reflecting the company's capital structure. Investors tracking ORTINGLOBE share price can monitor key metrics including P/E ratio, promoter holding of 1.23%, and quarterly earnings growth.
Company Details
Key Leadership
ORTINGLOBE Share Price: Frequently Asked Questions
What is the current share price of Ortin Global Ltd (ORTINGLOBE)?
As of 18 Feb 2026, 10:41 am IST, Ortin Global Ltd share price is ₹18.06. The ORTINGLOBE stock has a market capitalisation of ₹10.59 (Cr) on NSE/BSE.
Is ORTINGLOBE share price Overvalued or Undervalued?
ORTINGLOBE share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 31.77x. Based on this relative valuation, the Ortin Global Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of ORTINGLOBE share price?
The 52-week high of ORTINGLOBE share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Ortin Global Ltd share price?
Key factors influencing ORTINGLOBE share price include quarterly earnings growth (Sales Growth: -80.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Ortin Global Ltd a good stock for long-term investment?
Ortin Global Ltd shows a 5-year Profit Growth of -16.00% and an ROE of -36.25%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.72 before investing in ORTINGLOBE shares.
How does Ortin Global Ltd compare with its industry peers?
Ortin Global Ltd competes with major peers in the Pharmaceuticals. Investors should compare ORTINGLOBE share price P/E of 0.00x and ROE of -36.25% against the industry averages to determine competitive standing.
What is the P/E ratio of ORTINGLOBE and what does it mean?
ORTINGLOBE share price has a P/E ratio of N/Ax compared to the industry average of 31.77x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is ORTINGLOBE performing according to Bull Run's analysis?
ORTINGLOBE has a Bull Run fundamental score of N/A/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ORTINGLOBE belong to?
ORTINGLOBE operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Ortin Global Ltd share price.
What is Return on Equity (ROE) and why is it important for ORTINGLOBE?
ORTINGLOBE has an ROE of -36.25%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Ortin Global Ltd generates profits from shareholders capital.
How is ORTINGLOBE debt-to-equity ratio and what does it indicate?
ORTINGLOBE has a debt-to-equity ratio of 0.72, which indicates moderate leverage that should be monitored.
What is ORTINGLOBE dividend yield and is it a good dividend stock?
ORTINGLOBE offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Ortin Global Ltd shares.
How has ORTINGLOBE share price grown over the past 5 years?
ORTINGLOBE has achieved 5-year growth rates of: Sales Growth -71.99%, Profit Growth -16.00%, and EPS Growth N/A%.
What is the promoter holding in ORTINGLOBE and why does it matter?
Promoters hold 1.23% of ORTINGLOBE shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Ortin Global Ltd.
What is ORTINGLOBE market capitalisation category?
ORTINGLOBE has a market capitalisation of ₹11 crores, placing it in the Small-cap category.
How volatile is ORTINGLOBE stock?
ORTINGLOBE has a beta of N/A. A beta > 1 suggests the Ortin Global Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ORTINGLOBE operating profit margin trend?
ORTINGLOBE has a 5-year average Operating Profit Margin (OPM) of -12.65%, indicating the company's operational efficiency.
How is ORTINGLOBE quarterly performance?
Recent quarterly performance shows Ortin Global Ltd YoY Sales Growth of -80.00% and YoY Profit Growth of -6.38%.
What is the institutional holding pattern in ORTINGLOBE?
ORTINGLOBE has FII holding of 1.68% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Ortin Global Ltd stock.